Changes between Version 1 and Version 2 of BioPhysicsX/Meetings/2023/2023-05-02


Ignore:
Timestamp:
May 2, 2023, 3:52:01 PM (19 months ago)
Author:
longkr
Comment:

--

Legend:

Unmodified
Added
Removed
Modified
  • BioPhysicsX/Meetings/2023/2023-05-02

    v1 v2  
    1 = BioPhysicsX meeting; 27Mar23; 08:00 =
     1= BioPhysicsX meeting; 02May23; 09:00 =
    22
    3 **Present:** AG, CJ, KL, IMcN, PP
     3== Agenda ==
    44
    5 == Notes ==
    6 
    7 1. //News and updates: // KL, All
    8  - CIO "Charged Particles for Cancer Therapy":
    9   - Constitution finalised.  Will be submitted this week.
    10  - Imperial strategy consultation:
    11   - Qualtrix input:
    12    - Required by 31Mar23.  KL and IMcN will coordinate their input.
    13    - KL/IMcN considering submitting "one pager" outlining ambitions for LhARA, LhARA initiative, and potential for multidisciplinary institute.
    14  - Planning round:
    15    - KL has submitted paragraph of input to Physics planning round submission.  IMcN considering submitting "matching" paragraph.
    16  - CNRS:
    17   - KL invited as part of "Brady party" to make presentation on LhARA (initiative) at meeting at CNRS HQ in Paris on 03/04Apr23.
    18   - Possible link between IRL and White City activity.
    19 
    20 2. //BioPhysicsX two-pager: // CJ, All
    21  - [raw-attachment:The-institute-v0_3.docx Version 0.3]
    22  - Discussion included the following pointers:
    23   - Need sentences at the beginning to place the initiative/institute in context;
    24   - Probably good idea to explain the breadth of the LhARA collaboration; 4-nations UK, international, Institut Curie in particular;
    25   - Need to emphasis key links with FOM/IC NHS H/c Trust (IMcN), OIRO (AG);
    26   - Add link to clinical applications: trials, transformation in clinical practice as ambition;
    27   - Line of sight to clinic; the "why" big picture;
    28   - Potential for spin-offs;
    29     - IBA, Hitachi, Mitsubishi, Procure: system-level potential for tie up with medical-equipment provider
    30     - Instrumentation and computing as incremental/long-term impact plan, and, no-loss theorem; valuable even if LhARA should fail.
    31   - Biological impact:
    32    - In particular, unique potential to provide capability to investigate "spatial/temporal impact of beams at very high doses"
    33 
    34  - We **agreed** that bullet level inout would be provided to CJ as follows:
     51. //Notes and actions: // All \\
     6 Input to CJ as follows:
    357  - **IMcN:** Pre-clincal/clinical facing aspects of institute initiative
    368  - **PP:** I/p on delivering "a new, novel, big, different thing"
    379  - **AG:** I/p on biology and capability for radiation biology
    3810
     112. //BioPhysicsX two-pager: // CJ, All
     12 - [raw-attachment: Draft 1]
    3913
    40 3. //Actions and next steps: // All
    41  - Update on two pager, ideally this week.
     143. //Evolution of CCAP: // KL, All
    4215
    43 4. //DONM//
     164. //Opportunity with CNRS IRC: // KL, All
     17
     185. //CIO submission: // KL, All
     19
     206. //Actions and next steps: // All
     21
     227. //DONM//
    4423 - In a month's time.
    4524
    46 5. //AoB//
     258. //AoB//
    4726
    4827----